These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

413 related articles for article (PubMed ID: 9441347)

  • 1. [Drug-clinics. The drug of the month. Imitrex nasal spray (sumatriptan)].
    Scheen AJ
    Rev Med Liege; 1997 Sep; 52(9):610-2. PubMed ID: 9441347
    [No Abstract]   [Full Text] [Related]  

  • 2. Sumatriptan. An updated review of its use in migraine.
    Perry CM; Markham A
    Drugs; 1998 Jun; 55(6):889-922. PubMed ID: 9617601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Sumatriptan nasal spray 20mg: efficacy, tolerance and quality of life in migraine patients].
    Géraud G; Valette C
    Rev Neurol (Paris); 2000 Jul; 156(6-7):646-53. PubMed ID: 10891800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and adverse events of subcutaneous, oral, and intranasal sumatriptan used for migraine treatment: a systematic review based on number needed to treat.
    Tfelt-Hansen P
    Cephalalgia; 1998 Oct; 18(8):532-8. PubMed ID: 9827244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical applications of new therapeutic deliveries in migraine.
    Dahlöf C
    Neurology; 2003 Oct; 61(8 Suppl 4):S31-4. PubMed ID: 14581656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topical agents in the treatment of cluster headache.
    Markley HG
    Curr Pain Headache Rep; 2003 Apr; 7(2):139-43. PubMed ID: 12628056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Open-labeled long-term study of the efficacy, safety, and tolerability of subcutaneous sumatriptan in acute migraine treatment.
    Göbel H; Heinze A; Stolze H; Heinze-Kuhn K; Lindner V
    Cephalalgia; 1999 Sep; 19(7):676-83; discussion 626. PubMed ID: 10524662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Sumatriptan nasal spray for the treatment of cluster headache].
    Watanabe M; Oda A
    No To Shinkei; 2005 Jan; 57(1):65-8. PubMed ID: 15782603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Aspirin, triptan tablet, nasal spray, injection. Even the most severe migraine capitulates].
    Wiedemann B
    MMW Fortschr Med; 2001 Apr; 143(16):6. PubMed ID: 11368000
    [No Abstract]   [Full Text] [Related]  

  • 10. [Migraine: sumatriptan].
    Yamada K; Naritomi H
    Nihon Naika Gakkai Zasshi; 2001 Apr; 90(4):607-12. PubMed ID: 11391907
    [No Abstract]   [Full Text] [Related]  

  • 11. Consistency of response to sumatriptan nasal spray across patient subgroups and migraine types.
    Ashford E; Salonen R; Saiers J; Woessner M
    Cephalalgia; 1998 Jun; 18(5):273-7. PubMed ID: 9673807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serotonin 1D (5-HT1D) agonists and other agents in acute migraine.
    Mathew NT
    Neurol Clin; 1997 Feb; 15(1):61-83. PubMed ID: 9058397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SUMATRIPTAN: a receptor-targeted treatment for migraine.
    Moskowitz MA; Cutrer FM
    Annu Rev Med; 1993; 44():145-54. PubMed ID: 8386498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sumatriptan: efficacy and contribution to migraine mechanisms.
    Pearce JM
    J Neurol Neurosurg Psychiatry; 1992 Dec; 55(12):1103-5. PubMed ID: 1336041
    [No Abstract]   [Full Text] [Related]  

  • 15. A case of chronic paroxysmal hemicrania responding to subcutaneous sumatriptan.
    Pascual J; Quijano J
    J Neurol Neurosurg Psychiatry; 1998 Sep; 65(3):407. PubMed ID: 9728969
    [No Abstract]   [Full Text] [Related]  

  • 16. How does sumatriptan nasal spray perform in clinical practice?
    Dahlöf CG; Boes-Hansen S; Cederberg CG; Hardebo JE; Henriksson A
    Cephalalgia; 1998 Jun; 18(5):278-82. PubMed ID: 9673808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Sumatriptan--future development, alternative features and potential new indications].
    Arnold WS
    Neurol Neurochir Pol; 1992; Suppl 2():49-56. PubMed ID: 1337767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The problems of migraine headache treatment].
    Vilionskis A; Vaitkus A
    Medicina (Kaunas); 2002; 38(7):679-84. PubMed ID: 12474651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How to assess patient preference of migraine treatments.
    Dahlöf C
    Cephalalgia; 1999 Jul; 19 Suppl 24():2-5; discussion 5-6. PubMed ID: 10526675
    [No Abstract]   [Full Text] [Related]  

  • 20. Tolerability of sumatriptan: clinical trials and postmarketing experience.
    Allen C; Dayno J
    Cephalalgia; 2001 Oct; 21(8):855-6. PubMed ID: 11737014
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 21.